# A Study of STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS)

> **NCT06910384** · PHASE2 · TERMINATED · sponsor: **New England Cell Therapeutics, Inc.** · enrollment: 1 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **BIOLOGICAL:** STR04

## Key facts

- **NCT ID:** NCT06910384
- **Lead sponsor:** New England Cell Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-08-12
- **Primary completion:** 2025-12-16
- **Final completion:** 2025-12-16
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** organizational restructure
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06910384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06910384, "A Study of STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06910384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*